RLBBX
Price
$38.60
Change
-$0.10 (-0.26%)
Updated
Oct 7 closing price
Net Assets
266.1B
TSHIX
Price
$15.97
Change
+$0.02 (+0.13%)
Updated
Oct 6 closing price
Net Assets
830.41M
Interact to see
Advertisement

RLBBX vs TSHIX

Header iconRLBBX vs TSHIX Comparison
Open Charts RLBBX vs TSHIXBanner chart's image
American Funds American Balanced R2
Price$38.60
Change-$0.10 (-0.26%)
VolumeN/A
Net Assets266.1B
Transamerica Multi-Asset Income I
Price$15.97
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets830.41M
RLBBX vs TSHIX Comparison Chart in %
View a ticker or compare two or three
VS
RLBBX vs. TSHIX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBBX is a Buy and TSHIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 266B vs. TSHIX (830M). TSHIX pays higher dividends than RLBBX: TSHIX (3.46) vs RLBBX (1.11). RLBBX was incepted earlier than TSHIX: RLBBX (23 years) vs TSHIX (12 years). RLBBX (1.32) is less costly to investors than TSHIX (0.73). RLBBX (44.00) and TSHIX (42.00) have comparable annual turnover. RLBBX has a lower initial minimum investment than TSHIX: RLBBX (250) vs TSHIX (1000000). TSHIX annual gain was more profitable for investors over the last year : 14.23 vs. RLBBX (9.12). TSHIX return over 5 years is better than : 60.38 vs. RLBBX (38.04).
RLBBXTSHIXRLBBX / TSHIX
Total Expense Ratio1.320.72183%
Annual Report Gross Expense Ratio1.320.73181%
Fund Existence23 years12 years-
Gain YTD13.76113.036106%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets266B830M32,048%
Annual Yield % from dividends1.113.4632%
Returns for 1 year9.1214.2364%
Returns for 3 years47.9648.8898%
Returns for 5 years38.0460.3863%
Returns for 10 years68.69117.0759%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMX5.310.34
+6.84%
EMX Royalty Corp
SMMT22.150.72
+3.36%
Summit Therapeutics
TUSK2.30N/A
N/A
Mammoth Energy Services
HURN150.20-0.12
-0.08%
Huron Consulting Group
APRE1.49-0.02
-1.00%
Aprea Therapeutics